9 results
8-K
BAX
Baxter International Inc.
23 Mar 20
Regulation FD Disclosure
5:01pm
Executive Officer, tested negative for COVID-19.
Since the emergence of COVID-19, the Company has implemented a detailed action plan, which includes taking
8-K
EX-99.1
BAX
Baxter International Inc.
17 Mar 20
Completes Financial Restatement Process
7:44am
Response toCOVID-19 Virus
Since the emergence ofCOVID-19 (coronavirus), Baxter has implemented a detailed action plan, which includes taking proactive
8-K
EX-99.1
BAX
Baxter International Inc.
19 Oct 06
Results of Operations and Financial Condition
12:00am
in use outside the United States, and is
awaiting FDA approval of its corrective action plan in the United
States.
-- Signing
8-K
EX-10.1
jgqjx
29 Jun 06
Entry into a Material Definitive Agreement
12:00am
- Prev
- 1
- Next